Viewing Study NCT04280159


Ignite Creation Date: 2025-12-24 @ 3:00 PM
Ignite Modification Date: 2025-12-24 @ 3:00 PM
Study NCT ID: NCT04280159
Status: COMPLETED
Last Update Posted: 2020-02-21
First Post: 2020-02-04
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Modern Hybrid Imaging in Patients With OSCC
Sponsor: Wuerzburg University Hospital
Organization:

Study Overview

Official Title: Modern Hybrid Imaging for Staging and Monitoring Patients With Oral Squamous Cell Carcinoma
Status: COMPLETED
Status Verified Date: 2020-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PETOSCC
Brief Summary: Prospective diagnostic study to determine the diagnostic accuracy of preoperative 18F--fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in detecting local tumor extent, cervical lymph node metastases and distant metastases/secondary primary tumor.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: